Do oleic acid and n-3 fatty acids prevent pancreatic cancer? data from a UK prospective study using 7-day food diaries. (13th March 2011)

• Record Type: Journal Article
• Authors: Banim, P J R; Luben, R; McTaggart, A; Khaw, K-T; Wareham, N; Hart, A R
• Is Part Of: Gut. Volume 60:(2011)Supplement 1
• Page Start: A77
• Page End: A77
• Publication Date: 2011-03-13
• Subjects: Aetiology -- Fatty acids -- Pancreatic cancer; Gastroenterology -- Periodicals; 616.33
• DOI: 10.1136/gut.2011.239301.158
• Languages: English
• ISSNs: 0017-5749

Abstract

Abstract : Introduction: There are plausible biological mechanisms for how both oleic acid and n-3 fatty acids may prevent the development of pancreatic cancer through their effects on cancer oncogenes, apoptosis and inflammatory processes. The aim of this study was to investigate the effect of these nutrients in a prospective cohort study, for the first time using seven-day food diaries (7-DFDs), the most accurate feasible method of estimating food intake in large scale epidemiological investigations. Methods: 25 639 participants (56% women), aged 40–74 years were recruited into the European Prospective Investigation into Cancer-Norfolk (EPIC-Norfolk) with 23 658 completing 7-DFDs at enrolment. The cohort was monitored for 16 years, using hospital records and cancer registry data to identify participants who developed pancreatic cancer with all notes reviewed to confirm diagnosis. The 7-DFDs recorded one week's diet including food types, frequency of consumption, quantities and cooking methods. A representative sample of 3970 as well as those with gallstone disease had their 7-DFDs coded by nutritionists using a computer program containing nutrient information on 11 000 food and 55 000 portion sizes. A cohort analysis used Cox regression to estimate sex specific hazard ratios (HR) for developing pancreatic cancer comparing fifths of: total dietary n-3 fatty acids, eicosapentaenoic acid (EPA), docosapentaenoic acid (DHA) and oleic acid intake, adjusted for the risk factors of age, gender, total energy intake, smoking and diabetes. Results: A total of 88 participants with a mean age at diagnosis of 72.2 years (SD=9.0 years) (55.5% women) developed pancreatic cancer with 77% having advanced disease. The interval between recruitment and diagnosis was 7.9 years (SD=3.7 years). Increased oleic acid intake was associated with a decreased risk of developing pancreatic cancer (highest fifth (23.7–78.3 g/day) versus lowest fifth (2.5–13.2 g/day), HR=0.29 95% CI 0.09 to 0.91) with a significant trend across fifths (per fifth increase, HR=0.72 95% CI 0.55 to 0.96 p=0.023). The population attributable fraction for an intake of less than 23.7 g/day of oleic acid was 32.1%. No associations were found for total dietary n-3 fatty acids (highest vs lowest fifth, HR=0.55 95% CI 0.24 to 1.30) or dietary EPA and DHA intake. Conclusion: An increased oleic acid intake may be involved in the aetiology of one-third of pancreatic cancer cases. No associations were found for n3 PUFA's. The findings suggest oleic acid should be measured in future aetiological work of this aggressive cancer.